Brief: Pfizer reaches settlement agreements with Dexcel Pharma, Hikma & Cipla for Vyndamax
28/04/2026 15:26
April 28 (Reuters) - Pfizer Inc PFE.N: PFIZER REACHES THREE SETTLEMENT AGREEMENTS FOR VYNDAMAX PFIZER REACHES THREE SETTLEMENT AGREEMENTS FOR VYNDAMAX PFIZER: SETTLEMENTS EXTEND EFFECTIVE U.S. PATENT EXPIRY DATE FOR VYNDAMAX TO JUNE 1, 2031 PFIZER: AS A RESULT OF SETTLEMENT, REVENUES ARE NOW EXPECTED TO REMAIN RELATIVELY STABLE FROM 2028 THROUGH MID-2031 Source text: ID:nBw7SkPXwa Further company coverage: PFE.N